pivalyloxymethyl butyrate has been researched along with Leukemia, Myeloid, Acute, M4 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aviram, A; Ben-Dror, I; Maron, L; Nudelman, A; Rabizadeh, E; Rephaeli, A; Shaklai, M | 1 |
1 other study(ies) available for pivalyloxymethyl butyrate and Leukemia, Myeloid, Acute, M4
Article | Year |
---|---|
Effect of the cytostatic butyric acid pro-drug, pivaloyloxymethyl butyrate, on the tumorigenicity of cancer cells.
Topics: Animals; Antineoplastic Agents; Butyrates; Carcinoma, Lewis Lung; Gene Expression Regulation, Neoplastic; Genes, jun; Genes, myc; Leukemia, Myelomonocytic, Acute; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; RNA, Neoplasm; Tumor Cells, Cultured | 1997 |